Jonathan Phillips Email and Phone Number
Jonathan Phillips work email
- Valid
- Valid
Jonathan Phillips personal email
- Valid
- Valid
- Valid
At Intellia Therapeutics, I'm leading nonclinical strategy as Vice President of Pharmacology & Toxicology. My experience developing gene editing therapies began at Vertex where I co-authored first-in-human applications for CTX001 (CASGEVY), in partnership with CRISPR Therapeutics. I've also built and led several translational and investigative safety teams during my time with Boehringer Ingelheim. Prior to industry, I was a Bioastronautics Fellow at NASA Ames Research Center in Mountain View, CA where we investigated basic principles of mechanobiology in space travel environments. I hold a PhD in cell biology from UMass-Worcester, where I was a NASA funded candidate. My 20+ year scientific record includes dozens of peer reviewed publications, book chapters, and invited presentations.
Intellia Therapeutics, Inc.
View- Website:
- intelliatx.com
- Employees:
- 446
-
Head Of Pharmacology And ToxicologyIntellia Therapeutics, Inc.Cambridge, Ma, Us -
Head Of Pharmacology & ToxicologyIntellia Therapeutics, Inc. Apr 2019 - PresentCambridge, Massachusetts, UsHead of pharmacology & toxicology for the company leading the world to genome editing cures. Led nonclinical development strategy enabling successful clinical starts for NTLA-2001 (ATTR), NTLA-5001 (AML), NTLA-2002 (HAE), and NTLA-3001 (AATD). We employ a modular genome editing platform to create diverse in vivo and cell therapies for a range of disease indications. -
Managing EditorEclipse Scientific Editing May 2005 - PresentUsEditing firm specializing in polished biomedical communication. Long track record of repeat Japanese and European clients. Services include reviewing and revising peer reviewed manuscripts, grants, posters and slides. -
FellowVertex Pharmaceuticals Aug 2016 - Apr 2019Boston, Ma, UsDiscovery toxicologist for Boston R&D portfolio. Program team nonclinical representative for CTX001 (exa-cel) to treat sickle cell disease and beta-thalassemia. Co-authored first-ever IND and CTA for a CRISPR/Cas9 edited investigative product. -
Senior Principal ScientistBoehringer Ingelheim May 2015 - Jul 2016Ingelheim Am Rhein, Rhineland-Palatinate, DeBuilt a Biophysics, Modeling & Simulation team focused on toxicity insights through quantitative systems biology, fueled by a hybrid computational and experimental laboratory. -
Principal ScientistBoehringer Ingelheim Jun 2010 - May 2015Ingelheim Am Rhein, Rhineland-Palatinate, DeBuilt and led safety biomarker laboratory. Research toxicologist for oncology biologics (Vienna, Austria). US R&D site liaison to global clinical biomarker team in Biberach, Germany. -
Expatriate Lab Leader, Clinical Biomarkers, Dmpk-DeBoehringer Ingelheim Jun 2012 - Jun 2013Ingelheim Am Rhein, Rhineland-Palatinate, DeContributed to strategic aspects of implementing biomarkers onto clinical studies. Team member for Phase 0 exploratory biomarker trials and priority discovery projects. -
Senior Scientist, Integrative ToxicologyBoehringer Ingelheim Dec 2006 - Jun 2010Ingelheim Am Rhein, Rhineland-Palatinate, DeFounded a cell biology lab to support mechanistic toxicology investigations. Managed four scientists and hosted various visiting experts, interns, postdocs and co-ops depending on project demands. -
Nephrotoxicity Working Group Co-ChairThe Critical Path Institute Jan 2010 - Jan 2012Achieved first-ever translational safety biomarker Letters of Support from FDA and EMA.Led team responsible for submissions supporting rat urinary NGAL and osteopontin as biomarkers of drug induced kidney injury. Member of Qualification Leadership Team (QLT) responsible for delivering biomarker qualification briefing materials, data, face-to-face presentations and regulatory interactions to FDA, EMA, and, PMDA. -
Postdoctoral FellowNasa Ames Research Center Sep 2004 - Dec 2006Moffett Field, California, UsFellowship awarded by USRA to join the Gravitational Biology Research Branch, studying mechanisms of microgravity associated bone loss. Managed transgenic colony used to study the role of molecular mechanotransducers in space travel. (See also: Matrix Biology (2008) 27:609-618). Contributed to joint spaceflight program with the Russian Institute of Biomedical Problems studying tissue regeration in lower vertebrates under microgravitational conditions. (See also: J of Gravit Physiol (2006) 13:185-188 & 193-196). Awarded second fellowship to lead research focused on p53 as a nexus of gravitational mechanosensing, cellular proliferation and radiation responsiveness. (See also: Radiation Research (2009) 171:283-289) -
Research AssociateBeth Israel Deaconess Medical Center Dec 1997 - Jul 1999Boston, Ma, UsAnn Thorac Surg (2001) 72:555-563 -
ScientistGenome Therapeutics Corp Jul 1996 - Dec 1997J Bacteriol (2001) 183:4823-38.
Jonathan Phillips Skills
Jonathan Phillips Education Details
-
University Of Massachusetts Graduate School Of Biomedical SciencesMechanobiology -
Florida Institute Of TechnologyMolecular Biology -
Florida Institute Of TechnologyPre-Medicine/Pre-Medical Studies
Frequently Asked Questions about Jonathan Phillips
What company does Jonathan Phillips work for?
Jonathan Phillips works for Intellia Therapeutics, Inc.
What is Jonathan Phillips's role at the current company?
Jonathan Phillips's current role is Head of Pharmacology and Toxicology.
What is Jonathan Phillips's email address?
Jonathan Phillips's email address is jo****@****hoo.com
What schools did Jonathan Phillips attend?
Jonathan Phillips attended University Of Massachusetts Graduate School Of Biomedical Sciences, Florida Institute Of Technology, Florida Institute Of Technology.
What are some of Jonathan Phillips's interests?
Jonathan Phillips has interest in Health.
What skills is Jonathan Phillips known for?
Jonathan Phillips has skills like Drug Development, In Vitro, Biotechnology, Biomarker Discovery, Toxicology, Cell, Drug Discovery, Molecular Biology, Assay Development, Pharmaceutical Industry, Life Sciences, Biochemistry.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial